TIPS-20 A RANDOMIZED, CONTROLLED TRIAL OF BERUBICIN, A TOPOISOMERASE II POISON THAT APPEARS TO CROSS THE BLOOD-BRAIN BARRIER (BBB), AFTER FIRST-LINE THERAPY FOR GLIOBLASTOMA MULTIF...

por Silberman, Sandra, Hsu, Sigmund, Muzyczenko, Zena, Picker, Donald
Publicado 2023

Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute m...

por Croucher, Peter J P, Ridinger, Maya, Becker, Pamela S., Lin, Tara L., Silberman, Sandra L., Wang, Eunice S., Zeidan, Amer M.
Publicado 2023